Scleroderma Therapeutics Market Size, Share & Industry Analysis, By Drug Class (Endothelin Receptor Antagonists (ERAs), Phosphodiesterase-5 (PDE-5) Inhibitors, Prostacyclin Pathway Agents, Immunosuppressants, Interleukin-6 (IL-6) Inhibitors, Antifibrotic Agents), By Disease Indication (Systemic Scleroderma & Localized Scleroderma), By Age Group (Pediatric, Adult, & Geriatric), By Type (Branded & Generic), By Route of Administration (Oral, Intravenous, Subcutaneous, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), & Regional Forecast, 2026-2034